News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Onyvax Limited Raises £8 Million To Advance Development Of Prostate Cancer Vaccine


5/8/2006 4:55:58 PM

Onyvax Ltd, the biotechnology company developing novel cancer therapies, today announces that it has raised £8 million in a Series C fundraising. The round was co-led by 3i and SR One with additional funds from Barrie Haigh, Merlin Biosciences, MB Venture Capital Fund 1 NV, Alta Berkley Venture Partners and Alberville Ltd.



comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES